Q&As

A new systematic review of 38 studies that assessed the impact of white noise machines on sleep indicates that more research is needed to assess the benefits and harms of these machines. Study author Mathias Basner, MD, PhD, answered our questions about these findings and their potential implications for practice.
In this Q&A, Page B. Pennell, MD, answers our questions about her study, which indicated that changes in antiepileptic drug dose appear to be more common among pregnant women compared with nonpregnant women.
Neurology Learning Network spoke with Philip Wang, whose study recently demonstrated that, for emergency department visits for migraine between 2010 and 2017, opioid prescriptions decreased and administration of guideline-recommended treatments increased.
Farrah Mateen, MD, PhD, from Harvard Medical School and Massachusetts General Hospital in Boston, answers our questions about current recommendations for COVID-19 vaccination among patients with multiple sclerosis, as well as key areas of future research.
Neurology Learning Network’s Huntington Disease Section Editor Joohi Jimenez-Shahed, MD, talks about potential drug therapies undergoing clinical trials—including tominersin, valbenazine, and pridopine—for the treatment of various aspects of Huntington disease.
The ongoing COVID-19 pandemic has significantly impacted the diagnosis, management, and treatment of obstructive sleep apnea—a condition that may independently increase risk for COVID-19-related morbidity and mortality among some individuals—according to a new systematic review. Lead author Michelle Miller, BSc, PhD, answered our questions about her review.
Brain structural changes during preclinical Alzheimer disease appear to have a biphasic trajectory, according to new findings. Neurology Learning Network spoke with first author Victor Montal, PhD(c), MSc, about these findings and their implications.
Neurology Learning Network spoke with Sami Khella, MD, who gave a talk on new and emerging therapies for amyloidosis at the American Neurological Association’s 145th Annual Meeting.
Researchers answered our questions about their recent study, which suggested that noninvasive retinal imaging parameters should be investigated further as potential biomarkers of Parkinson disease.
In a recent systematic review, investigators examined the effects of medical marijuana on neurological symptoms among patients with Huntington disease. Senior study author Rana Zeine, MD, PhD, MBA, answered our questions about the findings in this review and their clinical implications.